Search

FDA Updates
12/29/2021

The following is a listing of recent U.S. Food and Drug Administration (FDA) updates and activities: Padagis Issues Voluntary Nationwide Recall ...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

The U.S. Centers for Disease Control and Prevention (CDC) has updated recommendations for isolation and quarantine period for the general population. ...

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • All Healthcare Organizations

Due to the increased transmissibility of the SARS-CoV-2 Omicron variant and concerns about potential impacts on the healthcare system, the C...

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • All Healthcare Organizations

Wishing you a joyous holiday season with peace and cheer in the New Year. Happy Holidays from the StayAlert! Compliance Team...

Sources:
  • Miscellaneous
Relevant To:
  • All Healthcare Organizations
FDA Updates
12/23/2021

The following is a listing of recent U.S. Food and Drug Administration (FDA) updates and activities: ASPR Pauses Shipping of Bamlanivimab and Et...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

The U.S. Centers for Disease Control and Prevention (CDC) is encouraging healthcare providers to recommend to their patients to perform COVI...

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • Assisted Living,
  • Urgent Care,
  • Medical Office,
  • Critical Access Hospitals,
  • Home Health,
  • Hospitals,
  • Long Term Care,
  • Ambulatory Care,
  • Rural Health Clinics

The U.S. Department of Health and Human Services' (HHS) Office for Civil Rights (OCR) has issued guidance to help clarify how the Health Insu...

Sources:
  • Health Insurance Portability and Accountability Act
Relevant To:
  • All Healthcare Organizations
FDA Updates
12/20/2021

The following is a listing of recent U.S. Food and Drug Administration updates and activities: Possible False RPR Reactivity with BioPlex 2200 S...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

The Joint Commission’s (TJC) new and revised workplace violence prevention standards are effective January 1, 2022 and apply to TJC-accredited h...

Sources:
  • The Joint Commission
Relevant To:
  • Critical Access Hospitals,
  • Hospitals

The U.S. Centers for Disease Control and Prevention (CDC) has endorsed updated recommendations made by the Advisory Committee on Immunization Practice...

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • All Healthcare Organizations

In light of persistent and ongoing cyber threats, the Cybersecurity & Infrastructure Security Agency (CISA) urges critical infrastructure owners a...

Sources:
  • Miscellaneous
Relevant To:
  • All Healthcare Organizations
FDA Update
12/16/2021

The following is a listing of recent U.S. Food and Drug Administration (FDA) updates and activities: Class I Recall of Cardiosave Hybrid and Cardio...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations
FDA Updates
12/14/2021

The following is a listing of recent U.S. Food and Drug Administration (FDA) updates and activities: Two Lots of Veklury (Remdesivir) by Gilead: Re...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations
FDA Updates
12/09/2021

The following is a listing of recent U.S. Food and Drug Administration (FDA) updates and activities: Coronavirus (COVID-19) Update: FDA Expands ...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

The Joint Commission’s (TJC) new and revised performance improvement standards for the ambulatory care, behavioral health care and human service...

Sources:
  • The Joint Commission
Relevant To:
  • Behavioral Health - Outpatient,
  • Critical Access Hospitals,
  • Hospitals,
  • Long Term Care,
  • Ambulatory Care,
  • Office-Based Surgery,
  • Clinical Lab,
  • Behavioral Health - Inpatient